Prosecution Insights
Last updated: May 29, 2026

Examiner: MYERS, CARLA J

Tech Center 1600 • Art Units: 1634 1682

This examiner grants 49% of resolved cases

Performance Statistics

48.6%
Allow Rate
-11.4% vs TC avg
1,068
Total Applications
+47.0%
Interview Lift
1134
Avg Prosecution Days
Based on 1022 resolved cases, 2023–2026

Rejection Statute Breakdown

2.4%
§101 Eligibility
20.5%
§102 Novelty
42.1%
§103 Obviousness
24.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18636097 SALIVARY EXTRACELLULAR RNA BIOMARKERS FOR GINGIVITIS Non-Final OA The Regents of the University of California
17915071 COVALENT CHEMISTRY ENABLES EXTRACELLULAR VESICLE PURIFICATION ON NANOSUBSTRATES ? TOWARD EARLY DETECTION OF HEPATOCELLULAR CARCINOMA Non-Final OA The Regents of the University of California
18625400 COMPOSITIONS AND METHODS FOR DETECTION OF VIRAL PATHOGENS IN SAMPLES Non-Final OA Gen-Probe Incorporated
19270331 IDENTIFICATION AND USE OF CIRCULATING NUCLEIC ACID TUMOR MARKERS Non-Final OA The Board of Trustees of the Leland Stanford Junior University
17637410 BLOOD GENE BIOMARKERS TO DIAGNOSE AND PREDICT ACUTE REJECTION IN LIVER TRANSPLANT RECIPIENTS Final Rejection NORTHWESTERN UNIVERSITY
18012839 Signature miRNA To Predict Neonatal Opioid Withdrawal Syndrome (NOWS) Final Rejection TEXAS A & M UNIVERSITY SYSTEM
18742149 METHODS FOR DETECTING AND TREATING PROPRANOLOL SENSITIVE TUMORS Final Rejection University of South Florida
18825852 METHODS OF SELECTING AND TREATING CANCER SUBJECTS THAT ARE CANDIDATES FOR TREATMENT USING INHIBITORS OF PARP Non-Final OA Arima Genomics, Inc.
17091092 SYSTEMS AND ASSAYS FOR ASSESSING MICROSATELLITE INSTABILITY Non-Final OA Life Technologies Corporation
18812671 MICRONEEDLE DEVICES, AND USES THEREOF Final Rejection MiNDERA Corporation
17599681 ARYL HYDROCARBON RECEPTOR (AHR) ACTIVATION SIGNATURE AND METHODS FOR DETERMINING AHR SIGNALING STATUS Final Rejection DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS
17640823 ASSOCIATION BETWEEN 4 COPIES OF EXON 3 OF fAIM AND PROGRESSIVE CHRONIC KIDNEY DISEASE IN CATS Final Rejection Washington State University
17759974 METHOD FOR INTRAOPERATIVELY OR POSTOPERATIVELY DETECTING IDH1 AND IDH2 GENE MUTATIONS IN GLIOMA TUMORS AND PRIMERS USED IN THIS METHOD Non-Final OA BAHCESEHIR UNIVERSITESI
17654758 ASSAY FOR THE DIAGNOSIS OF DERMATOPHYTOSIS Final Rejection EUROIMMUN Medizinische Labordiagnostika AG
18021748 BICYCLE CONJUGATES SPECIFIC FOR NECTIN-4 AND USES THEREOF Non-Final OA BicycleTx Limited
18250496 METHOD, SYSTEM, AND KIT FOR IN SITU DETECTION OF MICRO RIBONUCLEIC ACID (miRNA) CARRIED BY EXTRACELLULAR VESICLES (EVs) Non-Final OA Qilu University of Technology (Shandong Academy of Sciences)
18295893 Synchronized Cell-Based Compositions Non-Final OA NeuroGX LLC
18040976 SINGLE NUCLEOTIDE POLYMORPHISMS AND TREATMENT OF INFLAMMATORY CONDITIONS Non-Final OA UNIVERSITY OF ARIZONA, ARIZONA BOARD OF REGENTS
17947871 LYMPHATIC FLUID FOR DIAGNOSTICS Non-Final OA THE WASHINGTON UNIVERSITY
17840801 METHOD OF DIAGNOSIS OF HEMOPHILIA Final Rejection Machaon Diagnostics, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month